|Year : 2020 | Volume
| Issue : 9 | Page : 5041-5045
Adherence of heart failure patients to heart failure medications and its determinants in the Aseer region, Southern Saudi Arabia
Hazim Saeed M. Raffaa, Bandar A Alasmari, Safar A Abadi, Metrek Ali Al Metrek, Hatim Saeed Raffaa, Hassan Zaher M. Al Qarni, Razan S Alhumayed, Fares Hamdi Al Hamad, Fayi Mohammed Almakhluti, Hassan Mohammed Al Mani, Faisal Mohammed Al Halafi, Malak Abdullah Assiri, Sameer Marei Al Qahtani
Department of Family and Community Medicine, College of Medicine, King Khalid University, Saudi Arabia
|Date of Submission||18-May-2020|
|Date of Decision||19-Jun-2020|
|Date of Acceptance||21-Jun-2020|
|Date of Web Publication||30-Sep-2020|
Dr. Hazim Saeed M. Raffaa
Family Medicine Resident (PYG3), Joint Program of Family Medicine, Abha
Source of Support: None, Conflict of Interest: None
Background: Heart failure is a complex clinical syndrome of cardiovascular disease. Heart failure occurs when the heart muscle is weakened and cannot pump enough blood to meet the body's needs for blood and oxygen. It is characterised by several attacks of dyspnoea, chest pain, orthopnea and pulmonary or systemic congestion. The heart inability to fulfill the demands of the body further failure of heart to pump the blood with normal efficiency. Lack of patients' adherence to their treatment may affect their clinical compensation. Aim: To assess the extent of assessing the level and predictors of medication adherence among patients with heart failure in the Aseer region. Methodology: A descriptive cross-sectional approach was used for targeting all registered heart failure patients attending the cardio clinic and chronic diseases clinic in Aseer region hospitals. Data were collected using a direct interview questionnaire that was developed by the researchers with the help of experts. Questionnaire included the patients' sociodemographic data, co-morbidities, disease-related data and drugs. Results: The study included 151 patients diagnosed with heart failure. About 66% of the patients were above the age of 60 years and 62.3% were males. Exact of 47% of the cases had the disease for less than 3 years and 43.7% of the patients had the treatment for more than 3 years. About 49% of the patients forget to have their medication at least once while 34.4% had problems remembering to take your medication. Totally, more than half of the patients had poor medication adherence and only 7.3% had a high adherence rate. Conclusions and Recommendations: In conclusion, the adherence rate for the patients' medication was poor due to forgetting to have the medications. Poor adherence was related more with single patients who are not working with poor income.
Keywords: Adherence, cardiac patients, compliance, heart failure, medications, predictors, Saudi Arabia
|How to cite this article:|
Raffaa HS, Alasmari BA, Abadi SA, Al Metrek MA, Raffaa HS, Al Qarni HZ, Alhumayed RS, Al Hamad FH, Almakhluti FM, Al Mani HM, Al Halafi FM, Assiri MA, Al Qahtani SM. Adherence of heart failure patients to heart failure medications and its determinants in the Aseer region, Southern Saudi Arabia. J Family Med Prim Care 2020;9:5041-5
|How to cite this URL:|
Raffaa HS, Alasmari BA, Abadi SA, Al Metrek MA, Raffaa HS, Al Qarni HZ, Alhumayed RS, Al Hamad FH, Almakhluti FM, Al Mani HM, Al Halafi FM, Assiri MA, Al Qahtani SM. Adherence of heart failure patients to heart failure medications and its determinants in the Aseer region, Southern Saudi Arabia. J Family Med Prim Care [serial online] 2020 [cited 2020 Oct 20];9:5041-5. Available from: https://www.jfmpc.com/text.asp?2020/9/9/5041/296371
| Background|| |
Heart failure (HF), also known as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs., HF is characterised by several attacks of dyspnoea, chest pain, orthopnea and pulmonary or systemic congestion. When this occurs, the heart is unable to provide adequate blood flow to other organs such as the brain, liver and kidneys., HF may be due to failure of the right or left or both ventricles.HF can effect the life and quality of the life of patients.
The goals of treatment for people with chronic HF are the prolongation of life, the prevention of acute decompensation and the reduction of symptoms, allowing for greater activity. Behavioural, medical and device treatment strategies exist, which can provide a significant improvement in outcomes, including the relief of symptoms, exercise tolerance and a decrease in the likelihood of hospitalisation or death. Patients non-adherence to their medications continue to challenge their efficacy, leading to poor outcomes with higher costs for patients and the healthcare system as a whole., Both terms and compliance have been used interchangeably. The term adherence means either a specific research measure for the regularity with which patients take their medicines, typically expressed as a percentage of prescribed days and a more general definition perhaps best described by a World Health Organisation (WHO) report, 'the extent to which a person's behaviour—taking medication, following a diet, and/or executing lifestyle changes—corresponds with agreed recommendations from a health care provider'.
It was observed that the chronic disease patients and the HF in the Abha primary health care centres are non-adherent to their medications. One of the important factors that may affect the treatment is continuity of care. This study is aiming to assess to adherence level among to HF patients in the Aseer region. However, their beginning begins with the atherosclerotic cycle several years ago owing to the cardiovascular risk factors, with specific weights in the global risk.,,
The current study aimed to assess the level and predictors of medication adherence among patients with HF in the Aseer region.
| Methodology|| |
A descriptive cross-sectional approach was used targeting all registered HF patients attending a cardio clinic and chronic diseases clinic in Aseer region hospitals including Aseer Central Hospital (ACH), Armed Forces Hospital Southern Region (AFHSR), Khamis Mushayet General Hospital (KMGH) and Ahad Rofidah General Hospital (ARGH). Data were collected using a direct interview questionnaire that was developed by the researchers with the help of experts. Questionnaire included the patients' sociodemographic data, co-morbidities, disease-related data and drugs. Morisky medication adherence scale (MMAS-4) consisting of four questions designed to describe the medication-taking behaviour of patients. It has dichotomous response categories with yes or no. The tool Cronbach's alpha for reliability is 0.61, which is questionable. The tool score range from 0–4. Score zero means high adherence, score of 1–2 means medium adherence and score of 3–4 means low adherence. Ethical approval was obtained from Research Ethical committee (REC), King Khalid University (KKU).
After data were collected, it was revised, coded and fed to statistical software IBM SPSS version 22. The given graphs were constructed using Microsoft Excel software. All statistical analyses were done using two-tailed tests and an alpha error of 0.05. P value of less than or equal to 0.05 was considered to be statistically significant. Frequency and percent were used to describe the frequency distribution of each category for patients' data, disease-related data, medications and their adherence level. Chi-square test was used to assess the association between all related patients factors and their adherence level. Multiple stepwise logistic regression analysis was used to identify the most significant predictors for patients' medication adherence.
| Results|| |
The study included 151 patients diagnosed with HF. About 66% of the patients were aged above 60 years and 62.3% were males. Exact of 56.3% of the patients were married and 37.3% were illiterate while 10.6% were highly educated. Considering employment, 43.7% of the patients were not working and 41.7% were retired. Monthly income was less than 8000 SR among 68.9% of the patients and 52.3% were from rural areas with the distance between residence and hospital exceeding 30 minutes among 47% of the cases. As for smoking, 67.5% of the patients were non-smokers and 13.9% were active smokers [Table 1].
|Table 1: Personal data of patients with heart failure in Aseer region, Saudi Arabia|
Click here to view
[Table 2] demonstrates HF related data. Exact of 47% of the cases had the disease for less than 3 years and 43.7% of the patients had the treatment for more than 3 years. About 48% of the patients had four drugs daily and 32.5% had four co-morbidities. Receiving pharmaceutical health education was reported by 63.6% of the patients and receiving HF control health education was among 53.6% of the patients.
|Table 2: Heart failure data among patients in the Aseer region, Saudi Arabia|
Click here to view
Considering medication adherence [Table 3], it was clear that 49% of the patients forget to have their medication at least once while 34.4% had problems remembering to take your medication. Also, 37.1% of the patients stopped medications when felt better and 27.2% stopped when felt worse. Totally, 53.6% of the patients had poor medication adherence and only 7.3% had a high adherence rate.
|Table 3: Treatment adherence among patients with heart failure in Aseer region, Saudi Arabia|
Click here to view
[Table 4] illustrates the relation between patients' data and their adherence to medications. About 58% of the widowed patients were adherent to treatment in comparison to 24% of the single patients with recorded statistical significance (P = 0.024). High adherence was also recorded among 54.5% of the patients with no work compared to 14.3% of those who worked at governmental jobs (P = 0.033). Exact of 51.9% of patients with low income (<8000 SR monthly) had high adherence to medications compared to none of those with higher income (P =.018). A high adherence rate was recorded for patients who had the treatment recently (<1 year) compared to 34.8% of those who had the treatment for more than 3 years (P =.001). Patients who received pharmaceutical health education had lower adherence to medications than those who did not (36.5% vs. 63.6%, respectively). Also, high adherence was recorded among 34.6% of those who received HF control health education compared to 60% of those who didn't (P =.002). About 33% of the patients who had diet control had a high adherence rate compared to 53.6% of those who didn't (P =.017).
|Table 4: Distribution of heart failure patients' adherence to their treatment according to patients' characteristics|
Click here to view
Multiple logistic regression model was performed including all factors. The factors included in [Table 5] were found to be the most significant. Marital patients had 42% more likelihood for high adherence than others (OR = 1.42) and high income was associated with 53% less likelihood for high adherence (OR = 0.47). High education associated with 18% less likelihood for high adherence (OR = 0.82) while the urban residence was associated with tripled likelihood for adherence to the patients' medications (OR = 3.1). More treatment duration (>3 years) was associated with 62% less likelihood for adherence to medications (OR = 0.38). Receiving pharmaceutical health education was associated with a 56% less likelihood for high medication adherence among the study patients (OR = 0.46).
|Table 5: Multiple stepwise logistic regression models for predictors of patients' adherence to treatment|
Click here to view
| Discussion|| |
Cardiovascular diseases (CVDs) including HF are now reported as the main cause of death and disability worldwide. The WHO reported that in the year 2008, out of 17.3 million CVD deaths globally, heart attacks (myocardial infarction) and strokes were responsible for 7.3 and 6.2 million deaths, respectively., According to the latest WHO data published in 2017 Coronary Heart Disease Deaths in Saudi Arabia reached 23,624 or 24.25% of total deaths. The age-adjusted death rate is 174.22 per 100,000 of the population ranks Saudi Arabia number 34 in the world. Many clinical trials were conducted to establish evidence-based medications that are effective in the treatment of CVD. These drugs will be ineffective if patients have poor adherence to their prescribed medications. Poor adherence to therapies has been linked to a variety of problems, including poor blood pressure control, re-hospitalisation and increased healthcare resource utilisation.
The current study aimed to assess the medication adherence rate among patients with HF in the Aseer region. The study revealed that more than half of the patients recorded poor adherence to the prescribed medications. The main factor behind poor adherence was forgetting of having the drugs. Patients who received health education regarding the nature of the disease and medications were also less adherent to the medications. This may be explained by that, those patients know about lifestyle and dietary modifications which made them more controlled even with negligence of drug intake. High education was inversely related to adherence as those with high education were mostly employed with many life burdens causing them not to remember their treatment regularly.
This may explain that the adherence rate was higher among patients who were not working as they are busy with no life matter keeping drug intake regularly. Also, patients who had the treatment for less than 1 year were more adherent to the treatment as.
This study depicted that physicians should pay more time in health education for the patients focusing on the importance of being controlled through lifestyle modifications and adherence to the prescribed treatments.
| Conclusions|| |
In conclusion, the adherence rate for the patients' medication was poor due to forgetting to have the medications. Poor adherence was related more with single patients who are not working with poor income. Adherence was better among newly diagnosed cases that had the treatment for a short duration. More attention should be paid to correctly detect the main causes behind this poor adherence to overcome and also to find alternative modern therapies if it is related to the drug or its side effects.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46.
Katz AM, Konstam MA. Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management. Lippincott Williams & Wilkins; USA, Philadelphia:2012.
Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: Symptoms, patterns of onset, and contributing factors. Am J Med 2003;114:625-30.
Braunwald E. The war against heart failure: The Lancet lecture. Lancet 2015;385:812-24.
Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL. Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage 2008;35:594-603.
Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, et al
. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail 2007;13:643-8.
Bui AL, Fonarow GC. Home monitoring for heart failure management. J Am Coll Cardiol 2012;59:97-104.
McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol 2004;44:810-9.
Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al
. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7.
Bansilal S, Castellano JM, Garrido E, Wei HG, Freeman A, Spettell C, et al
. Assessing the impact of medication adherence on long-term cardiovascular outcomes. J Am Coll Cardiol 2016;68:789-801.
Sabaté E, World Health Organization, editor. Adherence to long-term therapies. World Health Organization; 2003. p. 1. Establishes the domains of non-adherence used to categorize research interventions to improve adherence.
AlHadlaq RK, Swarelzahab MM, AlSaad SZ, AlHadlaq AK, Almasari SM, Alsuwayt SS, et al
. Factors affecting self-management of hypertensive patients attending family medicine clinics in Riyadh, Saudi Arabia. J Fam Med Prim Care 2019;8:4003-9.
Caruso Brown AE. Treating addiction as a terminal disease. N
Engl J Med 2020;382:207-9.
Tan XI, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). Innov Pharm 2014;5:5. doi: 10.24926/iip.v5i3.347.
O'donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al
. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010;376:112-23.
Mendis S, Puska P, Norrving B, World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization; 2011.
Yusuf S, Hawken S, Ôunpuu, Dans T, Avezum A, Lanas F, et al
. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.
Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev 2007;15:257-63.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]